David Jakeman - 18 Jan 2022 Form 4 Insider Report for CHIMERIX INC

Reporting relationship: Principal Accounting Officer
Issuer ticker: N/A
Reported as of: 18 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jan 2022, 17:59:41 UTC
Prior SEC filing: 30 Sep 2021
Next SEC filing: 04 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael Alrutz, Attorney-in-Fact

Key filing fact

David Jakeman filed Form 4 for CHIMERIX INC on 20 Jan 2022.

Key facts

This page summarizes David Jakeman's Form 4 filing for CHIMERIX INC.
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Jan 2022, 17:59.

Change

Previous filing in this sequence was filed on 30 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMRX transaction

Common Stock

Award

Transaction value: $0
Shares: +14,900
Change %: +14%
Price: $0.000000
Shares after: 120,966
Date: 18 Jan 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +29,900
Change %
Price: $0.000000
Shares after: 29,900
Date: 18 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,900
Exercise price: $5.62
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 3,725 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 3,725 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 3,725 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 3,725 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.

Footnote F2

1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.